0 0 0 0 0 0 0 0
Sign Up Today X
Thanks for submitting the form.
Stockreport

InStride Health Raises Oversubscribed $30 Million Series B to Expand Access to Best-in-Class Specialty Treatment for Pediatric Anxiety and OCD [Yahoo! Finance]

HubSpot, Inc. (HUBS)  More Company Research Source: Yahoo! Finance
Last hubspot, inc. earnings: 2/12 04:11 pm Check Earnings Report
US:NYSE Investor Relations: ir.hubspot.com
BOSTON, MA / ACCESSWIRE / March 27, 2024 / InStride Health , an outpatient provider of specialty pediatric anxiety and OCD treatment, announced the closing of an oversubscribed $30M Series B funding round. General Catalyst led investors and was joined by previous investors .406 Ventures, Valtruis, Mass General Brigham Ventures, and Hopelab Foundation. The new capital enables InStride Health to continue investing in clinical quality while expanding to new markets. This will allow InStride Health to further deliver on its mission of providing insurance-based access to best-in-class mental health care. With this investment, the company's total funding has now reached $56M. "General Catalyst is proud to partner with the mission-driven founders of InStride who have dedicated their careers to solving the adolescent mental health crisis," says Holly Maloney, Managing Director at General Catalyst. "We believe InStride is at the forefront of helping to democratize accessible, high-quality [Read more]
IMPACT SNAPSHOT EVENT TIME: HUBS
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Performance comparison Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
LAST PRICE
VWAP
High:
MAX UP
High:
Low:
MAX DOWN
Low:
%
 POST NEWS RANGE
%
PRICE CHANGE
PRICE CHANGE PERCENTAGE
S&P 500 (SPX)
%
 VOLUME RATIO
%
VOLUME (SHARES)
TICKS
AVG SHARES PER TRADE
Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS
Opt-in for
HUBS alerts
from News Quantified
HUBS
NEWS
HUBS
Earnings
HUBS
Analyst Actions
HUBS
SEC Filings
Stockreport

InStride Health Raises Oversubscribed $30 Million Series B to Expand Access to Best-in-Class Specialty Treatment for Pediatric Anxiety and OCD [Yahoo! Finance]

HubSpot, Inc.  (HUBS) 
More Company Research Source: Yahoo! Finance
Last hubspot, inc. earnings: 2/12 04:11 pm Check Earnings Report
US:NYSE Investor Relations: ir.hubspot.com
BOSTON, MA / ACCESSWIRE / March 27, 2024 / InStride Health , an outpatient provider of specialty pediatric anxiety and OCD treatment, announced the closing of an oversubscribed $30M Series B funding round. General Catalyst led investors and was joined by previous investors .406 Ventures, Valtruis, Mass General Brigham Ventures, and Hopelab Foundation. The new capital enables InStride Health to continue investing in clinical quality while expanding to new markets. This will allow InStride Health to further deliver on its mission of providing insurance-based access to best-in-class mental health care. With this investment, the company's total funding has now reached $56M. "General Catalyst is proud to partner with the mission-driven founders of InStride who have dedicated their careers to solving the adolescent mental health crisis," says Holly Maloney, Managing Director at General Catalyst. "We believe InStride is at the forefront of helping to democratize accessible, high-quality [Read more]
IMPACT SNAPSHOT
EVENT TIME:
HUBS
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Don't Miss Out On The Next BIG Stock Move
Performance comparison Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
LAST PRICE
VWAP
High:
MAX UP
High:
Low:
MAX DOWN
Low:
%
 POST NEWS RANGE
%
PRICE CHANGE
PRICE CHANGE PERCENTAGE
S&P 500 (SPX)
%
 VOLUME RATIO
%
VOLUME (SHARES)
TICKS
AVG SHARES PER TRADE
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS